Long term follow up (LTFU) study 16-20 yrs after hepatitis B vaccination in newborns of mothers who were seropositive for Hepatitis B envelope antigen (HBeAg) and Hepatitis B surface antigen (HBsAg)

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To evaluate the anti-HBs persistence up to Year 20 after the first vaccine dose of the primary vaccination. To evaluate the prevalence and incidence of other Hepatitis B markers (HBsAg, anti-bodies to Hepatitis B core antigen [anti-HBc], HBeAg, antibodies to Hepatitis B envelope antigen [anti-HBe]) up to Year 20 after the first vaccine dose of the primary vaccination. To evaluate the clinical significance of the HBsAg+ and anti-HBc+ cases observed during the long-term follow-up (LTFU) of this study.

Critère d'inclusion

Hepatitis B vaccination in healthy newborns of HBeAg+ and HBsAg+ mothers

Liens

euctr